
501 - 1000 employees
Founded 2009
🏥 Healthcare
🔧 Hardware
🤖 Artificial Intelligence
💰 $175M Post-IPO Secondary - PROCEPT BioRobotics on 2024-10
Healthcare • Hardware • Artificial Intelligence
PROCEPT BioRobotics is a medical technology company that develops AI-powered robotic systems for the surgical treatment of benign prostatic hyperplasia (BPH). Their flagship offering, Aquablation therapy delivered via the HYDROS and AquaBeam robotic systems, is an ultrasound-guided, robotic-assisted waterjet procedure designed to precisely remove prostate tissue while preserving sexual function and continence across prostates of varying shapes and sizes. The company emphasizes computer-assisted treatment planning, clinical evidence of safety and durability, and robotic hardware and software (including AI features) to support urologic surgery.
Selected: 🆕 Date Added.
🕒 August 21
Territory representative generating surgeon and hospital leads for PROCEPT BioRobotics’ Aquablation surgical robotics. Supporting product demonstrations and capital sales across Northern California.
🏄 California – Remote
💵 $95k / year
💰 $175M Post-IPO Secondary - PROCEPT BioRobotics on 2024-10
⏰ Full Time
🟠 Senior
✨ Representative
👻 Ghost score 0%
🕒 August 14
Strategic accounts manager selling PROCEPT’s Aquabeam surgical robotics system to hospitals treating BPH. Driving IDN sales, utilization growth, clinical support, and regional sales-team performance.
🏄 California – Remote
💵 $180k / year
💰 $175M Post-IPO Secondary - PROCEPT BioRobotics on 2024-10
⏰ Full Time
🟡 Mid-level
🟠 Senior
👔 Manager
👻 Ghost score 0%
🕒 June 28
Staff Regulatory Affairs Specialist at PROCEPT BioRobotics supporting regulatory compliance and strategy for medical devices. Collaborating on cross-functional teams to advance innovative surgical technologies.
🏄 California – Remote
💰 $175M Post-IPO Secondary - PROCEPT BioRobotics on 2024-10
⏰ Full Time
🔴 Lead
🚔 Compliance
👻 Ghost score 26%